GX-03
History
Earliest recorded event: Jul 11, 2025. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.
- Jul 11, 2025Phase 2/3 trial startedA Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema) ClinicalTrials.gov NCT07355075